Sale!

The Ordinary Granactive Retinoid 2% in Squalane 30ml

80.85 AED

-30%

This water-free solution contains a 2% concentration of an advanced retinoid active complex called Granactive Retinoid™

Out of stock

Notify me when the item is back in stock.

Add to Wishlist

Free & Fast Home Delivery within 48 Hours

  • Easy Return Policy
  • Quality Assured Products Delivered
Have Questions?

Technology:

This water-free solution contains a 2% concentration of an advanced retinoid active complex called Granactive Retinoid™ that has been shown to offer better results against multiple signs of aging than retinol without any of the irritation and drawbacks common with retinol. Granactive Retinoid™, an active technology from Grant Industries, is a solubilized system of Hydroxypinacolone Retinoate, a highly-advanced form of retinoid which is, in fact, a non-prescription ester of all-trans direct retinoic acid that offers a multi-fold better effect against signs of aging than retinol, retinyl palmitate and nearly all other forms of non-prescription retinoid.

This product uses next-generation retinoid active technologies which have been shown to achieve better reduction in signs of aging than retinol without irritation. These technologies cannot be compared directly with retinol itself in terms of concentration because they include a different retinoid molecule, in a similar way that Retinol cannot be compared with Retinoic Acid in terms of concentration. If you have an interest in a retinol product, please refer to our Retinol portfolio above which products contain pure retinol and cost less since many retinol technologies cost less than their next-generation counterparts like Granactive Retinoid™.

Caution: Retinoids can make the skin more sensitive to UV radiation. Sun protection is particularly important when using retinoids. This product must not be used in conjunction with other retinoids including retinol or retinoic acid. This product is not a treatment for acne. Acne-prone skin may experience a temporary increase in acne during the first few weeks of using any form of retinoid including those used in this formulation.

Note: When pregnant or breastfeeding, it is recommended to avoid any skincare products containing retinoids such as formulations with Granactive Retinoid™ or Retinol.

Granactive Retinoid™ is a trademark of Grant Industries. Neither DECIEM nor The Ordinary is affiliated with Grant Industries.

Directions:

Apply a small amount to face in the PM as part of your skincare regimen, after water-based serums but before heavier treatments. Do not use with other retinoid treatments. Avoid unprotected solar exposure. If irritation occurs, cease use and consult a physician. Use only as directed on unbroken skin. Patch testing prior to use is advised. Keep out of reach of children. Refrigerate after opening.

Patch tests are an easy way to help predict if you may experience a negative initial reaction to a new product. It is recommended to perform a patch test before incorporating any new product into your regimen. We have outlined a general method for conducting your own patch test below based on the type of product.

  • Apply a small amount of the product onto a clean area of skin on the upper forearm.
  • Keep the area dry.
  • If the product has a specified duration of use, rinse off after this time has elapsed. Otherwise rinse off after 24 hours.
  • If any redness, burning, itching, blistering or irritation is observed at any time throughout the test, do not use the product.

For more product specific information, review our Patch Testing Guide.

Ingredients:

Squalane, C12-15 Alkyl Benzoate, Bisabolol, Caprylic/Capric Triglyceride, Dimethyl Isosorbide, Simmondsia Chinensis (Jojoba) Seed Oil, Hydroxypinacolone Retinoate, Solanum Lycopersicum (Tomato) Fruit Extract, Rosmarinus Officinalis (Rosemary) Leaf Extract, Hydroxymethoxyphenyl Decanone.

Brand

The Ordinary

Reviews

There are no reviews yet.

Be the first to review “The Ordinary Granactive Retinoid 2% in Squalane 30ml”

Your email address will not be published. Required fields are marked *